TrialEpilepsia open2022

Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials.

Michael Rademacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.